Dr. / Dr Joseph LK Chin
Effect of 18F-DCFPyL PET/CT (PSMA PET) on management of suspected limited residual/recurrent disease following radical prostatectomy: a prospective, multicenter registry trial in Ontario
Mr. / M. Aurinjoy Gupta
Predictors of adverse outcomes for patients with high-risk and very high-risk prostate cancer undergoing radical prostatectomy: results from the Canadian high-risk prostate cancer collaboration
Dr. / Dr Laurence Klotz
A urinary exosome assay interrogating small non-coding RNAs accurately identifies and stratifies prostate cancer into low, intermediate, or high-risk disease
Dr. / Dr Gabriela Ilie
Prostate Cancer-Patient Empowerment Program (PC-PEP) randomized clinical trial: results of a 6-months intervention designed to reduce the burden of mental health among patients with curative disease
Dr. / Dr Adam Kinnaird
Prostate cancer of Indigenous men in Canada - identifying differences in diagnosis and treatment within a universal healthcare system
